The U.S. Centers for Disease Control and Prevention on Wednesday updated its respiratory syncytial virus vaccine guidelines, which now recommend the shots in all seniors aged 75 and older and in those 60 to 74 years of age who are at risk of severe disease.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,